These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36773475)

  • 1. Binocular benefit following monocular subretinal AAV injection in a mouse model of autosomal dominant retinitis pigmentosa (adRP).
    Ahmed CM; Massengill MT; Ildefonso CJ; Jalligampala A; Zhu P; Li H; Patel AP; McCall MA; Lewin AS
    Vision Res; 2023 May; 206():108189. PubMed ID: 36773475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
    Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
    Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice.
    Mao H; Gorbatyuk MS; Rossmiller B; Hauswirth WW; Lewin AS
    Hum Gene Ther; 2012 Apr; 23(4):356-66. PubMed ID: 22289036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.
    Orlans HO; Barnard AR; Patrício MI; McClements ME; MacLaren RE
    Hum Gene Ther; 2020 Jul; 31(13-14):730-742. PubMed ID: 32394751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of wild-type mouse rhodopsin using an AAV vectored ribozyme as part of an RNA replacement approach.
    Gorbatyuk MS; Pang JJ; Thomas J; Hauswirth WW; Lewin AS
    Mol Vis; 2005 Aug; 11():648-56. PubMed ID: 16145542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal degeneration in humanized mice expressing mutant rhodopsin under the control of the endogenous murine promoter.
    Liu X; Jia R; Meng X; Li Y; Yang L
    Exp Eye Res; 2022 Feb; 215():108893. PubMed ID: 34919893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme.
    Gorbatyuk M; Justilien V; Liu J; Hauswirth WW; Lewin AS
    Exp Eye Res; 2007 Jan; 84(1):44-52. PubMed ID: 17083931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
    Gorbatyuk M; Justilien V; Liu J; Hauswirth WW; Lewin AS
    Vision Res; 2007 Apr; 47(9):1202-8. PubMed ID: 17292939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector.
    Cideciyan AV; Sudharsan R; Dufour VL; Massengill MT; Iwabe S; Swider M; Lisi B; Sumaroka A; Marinho LF; Appelbaum T; Rossmiller B; Hauswirth WW; Jacobson SG; Lewin AS; Aguirre GD; Beltran WA
    Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8547-E8556. PubMed ID: 30127005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigma 1 receptor activation improves retinal structure and function in the Rho
    Barwick SR; Xiao H; Wolff D; Wang J; Perry E; Marshall B; Smith SB
    Exp Eye Res; 2023 May; 230():109462. PubMed ID: 37003581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa.
    Zhang X; Girardot PE; Sellers JT; Li Y; Wang J; Chrenek MA; Wu W; Skelton H; Nickerson JM; Pardue MT; Boatright JH
    Mol Vis; 2019; 25():462-476. PubMed ID: 31523123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated ERdj5 overexpression protects against P23H rhodopsin toxicity.
    Aguilà M; Bellingham J; Athanasiou D; Bevilacqua D; Duran Y; Maswood R; Parfitt DA; Iwawaki T; Spyrou G; Smith AJ; Ali RR; Cheetham ME
    Hum Mol Genet; 2020 May; 29(8):1310-1318. PubMed ID: 32196553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal histopathology in eyes from patients with autosomal dominant retinitis pigmentosa caused by rhodopsin mutations.
    Bonilha VL; Rayborn ME; Bell BA; Marino MJ; Beight CD; Pauer GJ; Traboulsi EI; Hollyfield JG; Hagstrom SA
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2161-9. PubMed ID: 26202387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of visual function and retinal structure following acute light exposure in the light sensitive T4R rhodopsin mutant dog.
    Iwabe S; Ying GS; Aguirre GD; Beltran WA
    Exp Eye Res; 2016 May; 146():341-353. PubMed ID: 27085210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations.
    Aleman TS; Cideciyan AV; Sumaroka A; Windsor EA; Herrera W; White DA; Kaushal S; Naidu A; Roman AJ; Schwartz SB; Stone EM; Jacobson SG
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1580-90. PubMed ID: 18385078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model.
    Mitra RN; Zheng M; Weiss ER; Han Z
    Biomaterials; 2018 Mar; 157():26-39. PubMed ID: 29232624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model.
    Du W; Li J; Tang X; Yu W; Zhao M
    Exp Biol Med (Maywood); 2023 Oct; 248(20):1818-1828. PubMed ID: 37837380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model.
    Patrizi C; Llado M; Benati D; Iodice C; Marrocco E; Guarascio R; Surace EM; Cheetham ME; Auricchio A; Recchia A
    Am J Hum Genet; 2021 Feb; 108(2):295-308. PubMed ID: 33508235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.
    Orlans HO; McClements ME; Barnard AR; Martinez-Fernandez de la Camara C; MacLaren RE
    Nat Commun; 2021 Aug; 12(1):4934. PubMed ID: 34400638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compensation of inner retina to early-stage photoreceptor degeneration in a Rho
    Wang B; Arbuckle RK; Davoli KA; Clinger OD; Brown R; Sahel JA; Chen Y; Pi S
    Exp Eye Res; 2024 Mar; 240():109826. PubMed ID: 38340947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.